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Abstract
Mel4 is a novel cationic peptide with potent activity against Gram-positive bacteria. The cur-
rent study examined the anti-staphylococcal mechanism of action of Mel4 and its precursor
peptide melimine. The interaction of peptides with lipoteichoic acid (LTA) and with the cyto-
plasmic membrane using DiSC(3)-5, Sytox green, Syto-9 and PI dyes were studied.
Release of ATP and DNA/RNA from cells exposed to the peptides were determined. Bacte-
riolysis and autolysin-activated cell death were determined by measuring decreases in
OD620nm and killing of Micrococcus lysodeikticus cells by cell-free media. Both peptides
bound to LTA and rapidly dissipated the membrane potential (within 30 seconds) without
affecting bacterial viability. Disturbance of the membrane potential was followed by the
release of ATP (50% of total cellular ATP) by melimine and by Mel4 (20%) after 2 minutes
exposure (p<0.001). Mel4 resulted in staphylococcal cells taking up PI with 3.9% cells pre-
dominantly stained after 150 min exposure, whereas melimine showed 34% staining. Unlike
melimine, Mel4 did not release DNA/RNA. Cell-free media from Mel4 treated cells hydro-
lysed peptidoglycan and produced greater zones of inhibition against M. lysodeikticus lawn
than melimine treated samples. These findings suggest that pore formation is unlikely to be
involved in Mel4-mediated membrane destabilization for staphylococci, since there was no
significant Mel4-induced PI staining and DNA/RNA leakage. It is likely that the S. aureus kill-
ing mechanism of Mel4 involves the release of autolysins followed by cell death. Whereas,
membrane interaction is the primary bactericidal activity of melimine, which includes mem-
brane depolarization, pore formation, release of cellular contents leading to cell death.
Introduction
S. aureus is a major cause of infections in both health care and community settings which can
produce high levels of mortality and have a high economic burden on society [1, 2]. S. aureus
can reside on the skin and in the nasal cavity of 20–50% humans [3, 4] and this poses a risk for
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subsequent infections [5]. S. aureus is also a major cause of infections of medical devices and
can cause 30–40% bacteraemia, surgical wound and implant-related infections [4, 6]. Methicil-
lin-resistant S. aureus (MRSA) now causes over 50% of skin and soft tissue infections [7]. The
mortality rate of S. aureus bacteraemia can reach up to 40% [8]. S. aureus associated infections
are difficult to treat with currently available antibiotics [9] partly due to the increase in MRSA
which are often very resistant to many different classes of antibiotics [6, 10]. To overcome
these problems, new antimicrobials are needed which have unique modes of action and limited
potential for resistance development.
Antimicrobial peptides (AMPs) exhibit broad spectrum antimicrobial activity against a
wide range of microorganisms including bacteria, fungi, parasites and enveloped viruses at
low concentrations [11–13]. AMPs are usually cationic in nature and have a varying number
(from five to over a hundred) of amino acids. AMPs possess multiple modes of action, rapid
bacterial killing kinetics and little toxicity toward human cells [14, 15]. Owing to the fact that
these molecules exhibit multifaceted modes of action and rapidly kill bacteria, development of
resistance in bacteria against AMPs is relatively rare [16, 17]. The mechanism of action of
AMPs is believed to start by interacting with the negatively charged lipoteichoic acid (LTA) or
teichoic acid of Gram-positive bacteria [18], through the negatively charge phosphate groups
in LTA [19, 20].
The interaction with LTA is then believed to facilitate penetration of AMPs through the
thick peptidoglycan layer, perhaps by the LTA acting as ladder, allowing the AMPs to reach
and act on the cytoplasmic membrane [18]. AMPs disrupt phospholipid lipid bilayers of bacte-
rial membranes by forming pores by various mechanisms called “barrel stave” or “toroidal
pore” or through disintegration of lipids via the “carpet model” [21]. Cytoplasmic membrane
collapse can result in leakage of cellular contents such as potassium ions, ATP and DNA/RNA
which in turn may lead to cell death [22, 23]. Some AMPs translocate across the cell membrane
and inhibit DNA/RNA or protein synthesis [24, 25]. AMPs can also kill Gram positive bacteria
by activating cell wall bound autolytic enzymes known as autolysins [26]. LTAs, which are
anchored in the cell envelope, control autolysin activity [27]. The interaction of AMPs with
LTA can result in loss of regulation of autolysins which then cause autolysis by hydrolysing
peptidoglycan chains and peptide bridges of murein [27].
Melimine is a cationic hybrid peptide of melittin and protamine [28]. It shows broad spec-
trum antimicrobial activity against Gram-negative and Gram-positive bacteria (including
MRSA), fungi and protozoan such as Acanthamoeba without inducing resistance in bacteria
[28, 29]. Melimine destroys the membrane potential of S. aureus [30]. Melimine, similarly to
some other antimicrobial peptides such as Esculentin-1a and LL-37 [31], when covalently
bound to polymers such as contact lenses inhibits initial bacterial attachment and can kill
microbes [28, 29]. A shorter sequence of melimine, called Mel4, has a relatively low minimum
inhibitory concentration against S. aureus (53.2 μM) and kills S. aureus when immobilized on
surfaces [32]. It is non-cytotoxic to mammalian cells in vitro [28, 29]. Mel4 has improved ocular
compatibility compared to melimine when bound to contact lenses [33]. Mel4 lacks the amino
acids tryptophan, leucine and isoleucine that are present in the sequence of melimine. Trypto-
phan is a highly lipophilic amino acid [34] and its presence is often an important part of the
activity to AMPs [35–37]. Leucine and isoleucine are hydrophobic residues which promote
strong α-helix formation in AMPs which in turn results a higher degree of membrane disrup-
tion [38, 39]. Although various studies have shown that Mel4 has high bactericidal activity
against staphylococci, the mode of action of Mel4 is not yet understood. Given the shorter pep-
tide length and the unique amino acid sequence compared to melimine, an investigation of the
killing mechanism of Mel4 against Gram-positive bacteria is necessary. Hence, this study was
designed to evaluate the mode of action of Mel4 in comparison with melimine against S. aureus.
Mechanism of action of cationic antimicrobial peptide Mel4
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Materials and methods
Synthesis of peptides
Melimine (amino acid sequence: TLISWIKNKRKQRPRVSRRRRRRGGRRRR;
molecular mass 3786.6) and Mel4 (KNKRKRRRRRRGGRRRR; 2347.8) were
synthesized by conventional solid-phase peptide protocols [40, 41] and procured from the
Auspep Peptide Company (Tullamarine, Victoria, Australia). The purity of the purchased pep-
tides was�90%.
Bacterial strains and growth conditions
S. aureus 31 (contact lens induced peripheral ulcer isolate) [42], S. aureus 38 (microbial kerati-
tis isolate) [43], and the type strain of S. aureus, ATCC 6538 (isolated from a “human lesion”
according to the ATCC website) [44] were used in the current study. Bacteria were grown
from frozen stocks overnight at 37 oC to mid-log phase in Tryptic Soy Broth (TSB; Oxoid,
Basingstoke, UK) and cells were harvested following washing with phosphate buffer saline
(PBS, NaCl 8 g/L, KCl 0.2 g/L, Na2HPO4 1.4 g/L, KH2PO4 0.24 g/L; pH 7.4) then diluted in the
PBS containing 1/1000 TSB to OD600nm 0.05–0.06 (1× 107 colony forming units (CFU)/ml
confirmed upon retrospective plate counts on TS agar (Oxoid)). Cells prepared this way were
used in most experiments except for assessing the minimum inhibitory and bactericidal con-
centrations, measuring the release of DiSC3-5 from cells, and the autolytic activity assay.
Minimum inhibitory and minimum bactericidal concentration
The minimum inhibitory and minimum bactericidal concentrations of melimine and Mel4
were determined for all strains using a modified version of the Clinical Laboratory and Stan-
dard Institute (CLSI) broth microdilution method as described previously [45]. Bacterial sus-
pensions were prepared to a final concentration of 5×105 CFU ml−1 in Muller Hinton Broth
(MHB, Oxoid) and added to wells in a sterile 96-well microtiter plate containing two-fold dilu-
tions of each peptide with 0.01% v/v acetic acid (Sigma Aldrich, St Louis, MO, USA) and 0.2%
w/v bovine serum albumin (Sigma Aldrich). The plate was incubated at 37˚C for 18 h-24 h.
The MIC was set as the lowest concentration of peptides that reduced bacterial growth
by� 90% while the MBC was set as the lowest concentration of peptides that reduced bacterial
growth by>99.99% after enumeration of viable bacteria by plate counts compared to bacteria
grown without either AMP.
Interaction with LTA
Two experiments, bacterial growth in the presence of LTA and the amount of LTA in solution
measured by ELISA, were performed to determine the interaction of melimine and Mel4 with
LTA. Growth of S. aureus 38 was conducted in the presence of melimine or Mel4 following a
method of Yang and Yousef [46]. S. aureus LTA (Sigma Aldrich; 100 μg/ml) was dissolved in
MHB in wells of a 96-well microtiter plate containing S. aureus (5 ×105 CFU/ml) followed by
addition of 100 μl of melimine or Mel4 to achieve their MICs. The OD600nm was determined
over time during incubation at 37 OC. A growth curve was constructed over 12 h. Controls
were bacteria grown in the presence of LTA alone and bacteria grown in MHB alone (a mea-
sure of maximum bacterial growth).
A competitive ELISA using kit (My BioSource, San Diego, CA, USA) was performed to
evaluate whether melimine and Mel4 could bind and neutralize LTA of S. aureus. LTA (200
ng/ml) was dissolved in endotoxin free water (Sigma Aldrich) with melimine or Mel4 at their
MICs or MBCs as final concentrations and incubated for 1–2 h at 37 oC. Interaction of LTA
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with melimine and Mel4 was assessed as an increase in OD450nm compared to negative control
without peptides according to manufacturer instructions.
Cytoplasmic membrane disruption
The effect of melimine and Mel4 on the cytoplasmic membrane of S. aureus was assessed in
three experiments. To examine membrane depolarization, the release of the membrane poten-
tial sensitive dye DiSC3-5 was measured. Sytox Green and Propidium Iodide (PI) dyes were
used to determine whether the peptides could damage the cytoplasmic membranes and allow
the stains to penetrate and interact to intracellular nucleic acids. Sytox Green has a molecular
mass of 213.954 g/mol and a topological polar surface area of 28.7 A2 [47] whereas PI has a
molecular mass of 668.087 g/mol and a topological polar surface area of 55.9 A2 [48]. Penetra-
tion of these two dyes through compromised membrane occurs through pores and differences
may indicate different pore structures/sizes created by peptides.
Cytoplasmic membrane depolarization was performed as described by Rasul et al., [30]. Ali-
quots 100 μl bacteria labelled with 4 μM DiSC3-5 (Sigma Aldrich, St Louis, MO, USA) in HEPES
and 100 μl of melimine and Mel4 at their MICs and MBCs (as final concentrations) were added
to wells of 96 well microtiter plates. Increases in fluorescence were determined at 30 second inter-
vals at an excitation wavelength of 622 nm and an emission wavelength of 670 nm over five min-
utes. Aliquots of bacteria were withdrawn over the time course and serially diluted in Dey-Engley
(D/E neutralizing broth (Remel, Lenexa, KS, USA)) then plated on Tryptic Soy Agar (Oxoid,
Basingstoke, UK) containing phosphatidylcholine (0.7 g /L) and Tween 80 (5ml/L) then incubated
at 37 oC overnight. The number of live bacteria were enumerated and expressed as CFU/ml. A
positive control of dimethyl sulfoxide (DMSO) (Merck, Billerica, MA, USA) HEPES (100 μl) was
used to disrupt the cytoplasmic membrane potential of bacteria [49]. Initially a range of DMSO
concentrations (1%, 2%, 5% and 20% (v/v)) were tested to determine which concentration gave
maximum deporization. 20% DMSO gave maximum concentration and used in the assay.
Sytox green assay was performed following the established protocol of Li et al.,[50]. The
protocol was modified as to use TSB media instead of LB media, as TSB was used in all other
experiments. Bacterial cells in PBS (100 μl) were dispensed into wells of 96-well plates along
with 5μM Sytox green (Invitrogen, Eugene, Oregon, USA). Plates were incubated for 15 min-
utes in the dark at room temperature and then 100 μl of melimine or Mel4 were added so as to
achieve their MICs and MBCs. Fluorescence was measured spectrophotometrically (at an exci-
tation wavelength of 480 nm and an emission wavelength of 522 nm) every 5 minutes up to 30
minutes, and then after 150 minutes. Triton X-100 1% (v/v) (Sigma Aldrich, St Louis, MO,
USA) in PBS with 1/1000 TSB (100 μl) was used as positive control to disrupt the cytoplasmic
membrane of bacteria.
Flow cytometry was used to determine the ability of melimine and Mel4 to permeabilize the
cytoplasmic membrane of S. aureus 38 only. Bacteria were incubated simultaneously with
SYTO9 (7.5 μM) and PI (30 μM; Invitrogen, Eugene, Oregon, USA) and incubated at room
temperature for 15 min. Fluorescence intensities were recorded with a LSRFortessa SORP
Flow cytometer after addition of melimine or Mel4 at their MIC at different time points. The
wavelength of green fluorescence was (525/550 nm) for SYTO9 and a red fluorescence (610/20
nm) for PI [51]. Data were acquired and analysed using Flowjo software (version 10.5.0, Ore-
gon, USA). A minimum 20000 events were recorded for each sample.
Leakage of intracellular contents
Two assays, ATP release and loss of DNA/RNA. were performed to determine the leakage of
intracellular contents. Bacterial suspensions (100 μl) were added to melimine and Mel4 at their
Mechanism of action of cationic antimicrobial peptide Mel4
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MICs and MBCs and incubated at 37˚C for 10 minutes. Samples were withdrawn at two min-
utes intervals and centrifuged at 9000 × g for five minutes, and the supernatant removed and
kept on ice until further analysis. For determination of total ATP, the bacterial pellet was resus-
pended in boiling 100 mM Tris, 4 mM EDTA pH (7.4) and further incubated for 2 mins at
100˚C to lyse all the cells. The lysed cells were centrifuged at 9600 × g for two minutes and the
supernatant was kept on ice until further use [52]. Subsequently, both total and released ATP
were determined using an ATP bioluminescence kit (Invitrogen, Eugene, Oregon, USA)
according to the manufacturer’s instructions.
The loss of DNA/RNA was determined by following a method of Carson et al., [53]. Bacte-
ria (100 μl) were incubated at 37 oC with melimine and Mel4 at their MICs and MBCs. Sam-
ples were withdrawn at 5 minutes intervals, diluted (1:10) and filtered through 0.22 μm pores
(Merck, Tullagreen, Ireland). The OD260nm of the filtrates was measured in a UV-star plate
(Greiner Bio-one GmbH, Frickenhausen, Germany). The results were expressed as the ratio to
the initial OD260nm.
Lysis of bacteria
The bacteria-lytic potential of the two peptides was evaluated using two different bacterial
inoculums 1× 108 CFU/ml (OD660 0.1) and 3 × 1010 CFU/ml. The smaller inoculum size was
used to see whether OD620nm was measurable at the concentration of cells used in all other
assays. However, no measurable optical density change at 620nm was obtained, and so a larger
inoculum of 3 × 1010 CFU/ml was used. The larger inoculum was obtained by adjusting
OD620nm to 0.3, and bacterial numbers (CFU/ml) were confirmed upon retrospective plate
count. Melimine and Mel4 were added at their MICs and MBCs. Bacterial cultures were
immediately mixed and then diluted 1:100 in (1/1000 TSB). The OD620nm was measured and
additional readings were taken at 30, 60, 90, 120 minutes, 6.5 and 24 h after incubating at
room temperature. Peptides at their respective concentrations in 1/1000 TSB were used as
blanks. The results were recorded as a ratio of OD620nm at each time point compared to the
OD620nm at 0 minutes [53].
Time kill assay
Aliquots of bacterial cells (100 μl; 1× 107 CFU/ml) were added to melimine or Mel4 at their
MICs and MBCs (as final concentration) in 96 well plates and incubated at 37 ˚C with gentle
shaking. Aliquots (100 μl) were withdrawn at specified time points, serially diluted into D/E
neutralizing broth and plated onto Tryptic Soy agar containing phosphatidylcholine (0.7 g /L)
and Tween 80 (5ml/L). Bacterial colonies were counted after 24 h of incubation at 37 oC. Via-
ble bacteria were reported as log10 CFU/ml. A control of bacterial suspensions without peptide
was performed under the same conditions. The assay was performed in triplicate.
Release of autolysins
The presence of autolysins in supernatants of strains (S. aureus 31 and S. aureus 38) grown in
the presence of melimine and Mel4 was determined spectrophotometrically by the ability of
the supernatants to decrease the optical density of Micrococcus luteus peptidoglycan (PGN;
Sigma Aldrich, St Louis, MO, USA) following a published method [54]. Bacteria were grown
in MHB and harvested by washing three times with PBS. Bacteria were resuspended in the
same PBS to an OD660nm of 0.1 (1× 108 CFU/ml). The bacterial suspension (100 μl) was incu-
bated at 4X MIC of melimine or Mel4 for 5 h at 37 oC. Following centrifugation at 2000 × g for
10 minutes at 4 oC, the supernatant was recovered and filtered through 0.2 μm filter (Merck,
Tullagreen, Ireland). The filtrate was saturated with 75% ammonium sulphate at 4 oC with
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continuous mixing for 1 h. This mixture was centrifuged at 12000 × g at 4 oC for 30 min, the
supernatant was discarded, and the pellet was resuspended in 0.1 M sodium acetate buffer (pH.
6) and dialysed against four changes of buffer using Amicon ultra centrifugal filters (Merck,
Millipore, Tullagreen, Carrigtwohill, IRL). The retentate was recovered and incubated with
100 μl of Micrococcus luteus peptidoglycan (1 mg/ml) at room temperature for 3 h. OD570 nm
was initially determined at 0 min and then every 30 min intervals until 3 h. Results were pre-
sented as a ratio of OD570 nm at each time point versus OD570nm at 0 minutes (in percentage).
The retentate from the above assay was also used to detect the autolytic activity against a lawn of
Micrococcus lysodeikticus ATCC 4698. Briefly, 10 μL of each retentate from the above assay was
spotted onto a pre-seeded lawn of M. lysodeikticus (108 CFU/ml) on nutrient agar. Following
incubation for 24 h at 37˚C, the size of the zone of inhibition was measured. Lysozyme (5 mg/
ml) used as a positive control for maximum growth inhibition. Melimine or Mel4 dissolved in
PBS at 4X MIC was treated in exactly the same way but in the absence of bacteria, to test
whether any of the inhibitory activity in both assays (PGN and lawn of bacteria) was due to the
presence of these peptides.
Lysis of horse red blood cells
The hemolytic activities of both the peptides were determined using horse red blood cells
(HRBCs; Sigma) as described previously [28]. The HRBCs were washed three times with PBS
at 470 × g for 5 minutes. Peptides (16.50 μM to 3407.36 μM, in PBS) were added to the washed
HRBCs and incubated at 37˚C for 4 h. After incubation, the cells were pelleted at 1057 × g for
5 minutes, and supernatant was removed to assess the release of haemoglobin by measuring
OD540nm. HRBCs in PBS and HRBCs in distilled water were used as negative and positive con-
trols, to achieve 0% and 100% lysis respectively. The relative OD of HRBCs treated with each
peptide were compared to that treated with distilled water to determine the relative percentage
of hemolysis. The therapeutic index of the peptides was calculated by the ratio of hemolytic
activity and minimum inhibitory concentration.
Statistical analyses
Statistical analyses were performed using GraphPad Prism 7.02 software (GraphPad Soft-
ware, La Jolla, CA, USA). The effect of the different concentrations of peptides in each assay
compared to controls was analysed using two-way ANOVA with Tukey’s test of multiple
comparisons. Correlations between release of extracellular ATP and bacterial death were
examined using Pearson correlation test. Oneway ANOVA with Bonferroni test was used to
analyse the hemolytic effect on horse red blood cells. Statistical significance was set as
p<0.05.
Results
Inhibitory concentrations of the two peptides
The MICs and MBCs for melimine or Mel4 against S. aureus are shown in Table 1. Both meli-
mine and Mel4 were most active against S. aureus ATCC 6538. Melimine had lower MIC and
MBC compared to Mel4 for all strains.
In all subsequent experiments data of the assays for S. aureus 38 is presented. Data for all
other strains are presented in the supporting information (S1–S8 Tables). Both the AMPs dis-
played similar modes of action against all the strains of S. aureus.
Mechanism of action of cationic antimicrobial peptide Mel4
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Interaction with LTA
Melimine at its MIC (33.01 μM) and Mel4 at its MIC (66.02 μM) inhibited the growth of S.
aureus (Fig 1) with OD600 nm<0.2 after 14 hours of growth. However, in the presence of LTA
S. aureus could grow with significant increases in OD600nm starting after 6 h (p<0.001; Fig 1)
with both peptides. At 6 h, the OD600nm was not different between melimine-LTA and
Mel4-LTA (p = 0.601). However, at 8 h, the OD600nm with Mel4-LTA was significantly higher
(p = 0.005) than melimine-LTA. The presence of LTA alone did not affect the growth of S.
aureus and growth pattern was similar as in MHB alone.
In the ELISA assay at their MICs, melimine neutralized 1.2±0.1 ng LTA/nmol and Mel4
neutralized 1.1±0.1 ng LTA/nmol (p>0.999). Similarly, at their bactericidal concentrations
they neutralized 0.8±0.1 ng/nmol and 0.6±0.1 ng/nmol respectively (p>0.777).
Membrane disruption
Melimine depolarized the cytoplasmic membrane of S. aureus in a predominantly concentra-
tion independent manner. An increase in fluorescence intensity was detected as early 30 sec-
onds after addition of either peptide to all strains of S. aureus. The increase in fluorescence was
continuous until at 180 sec and became constant after this time until the last observation at
300 sec (Fig 2). The fluorescein intensity was not statistically different at the MIC and MBC of
melimine (p>0.999). However, at its MBC Mel4 yielded a significantly higher fluorescence
than at its MIC at 60 to 90 sec (p<0.05) and after this time the degree of depolarization was
similar for both the concentrations. This depolarization of the cytoplasmic membrane was not
directly associated with the bacterial death as only< 0.5 log10 bacteria were affected with both
the peptides at either concentration (Fig 2).
The fluorescence of Sytox green increased over time only with melimine and no fluores-
cence was detected with Mel4. Melimine at its MIC or MBC permeabilized the cell membrane
and the fluorescence increased significantly after 10 minutes of exposure compared to buffer
treated controls (p<0.026) (Fig 3). The intensity of fluorescence gradually increased over 150
minutes for both the concentrations of melimine against all strains, but no significant differ-
ence was observed between the MIC and MBC (p>0.999). Treatment with the positive control
Triton-X 100 resulted emission of higher Sytox green fluorescence compared to either peptides
within 10 minutes (p<0.001).
The membrane damaging effect of these peptides was also assessed with S. aureus 38 only
by flow cytometry in the presence of the DNA intercalating dye PI and the membrane perme-
able dye Syto-9 (Fig 4). After 30 minutes exposure to melimine at its MIC, 22.2% of cells had
high levels of Syto-9 staining but low levels of PI, 66.31% of cells had high levels of both Syto-9
and PI staining and 10.1% of cells had high levels of PI but low levels of Syto-9 staining. The
total percentage of cells with high levels of PI staining after 30 minutes exposure to melimine
Table 1. MIC and MBC values of melimine and Mel4 against S. aureus.
Bacterial strains Melimine Mel4
MIC (μM) MBC (μM) MIC (μM) MBC (μM))
S. aureus 31 33.01 66.02 106.48 212.96
S. aureus 38 33.01 66.02 106.48 212.96
S. aureus ATCC 6538 16.50 16.50 53.24 53.24
MIC = minimum inhibitory concentration that kills�90% of the positive control
MBC = minimum bactericidal concentration that kills�99.99% of bacteria.
https://doi.org/10.1371/journal.pone.0215703.t001
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was 76.41%. Whilst after 150 minutes the total number of PI stained cells remained approxi-
mately the same at 80.4%, the proportions had changed with 34.2% of cells having high levels
of PI staining and low levels of Syto-9 staining and 46.2% having high levels of both Syto-9 and
PI staining. The time course of staining with Mel4 at its MIC was different to melimine. After
30 minutes incubation, 55.3% of cells had high levels of Syto-9 staining but low levels of PI,
32.8% of cells had high levels of both Syto-9 and PI staining and 3.58% of cells had high levels
of PI but low levels of Syto-9 staining. The total percentage of cells with high levels of PI stain-
ing after 30 minutes exposure to melimine was 36.4%. After 150 minutes the total number of
PI stained cells remained approximately the same at 41.6%, as did the relative proportions
with 3.91% of cells having high levels of PI staining and low levels of Syto-9 staining and 37.7%
having high levels of both Syto-9 and PI staining. However, when looking at the flow cytome-
try readout (Fig 4) there did appear to be a general increase in the percentage of double stained
cells, but the gating did not bin cells with sufficiently fine detail. There was a difference in the
kinetics of cell death with the positive control Triton-X 100 (1%), which after 30 minutes
stained 16.34% cells with high PI and increased up to 24.94% after 150 min incubation. With
buffer treated (negative control) cells> 86% were stained with high levels of Syto-9 and low
levels of PI even after 150 minutes incubation (Fig 4).
Fig 1. Growth of S. aureus in the presence and absence of LTA. The antibacterial effect of melimine and Mel4 was significantly reduced by addition of
LTA compared to peptides alone after 6 h of incubation. The LTA alone had higher effect than LTA with any peptides at 6 h. Mel4-LTA increased OD600
nm more than melimine-LTA at 8 h. Error bars represents the means (±SD) of three independent experiments performed in triplicate. � represent
p�0.001, �� p�0.0001 and # p = 0.005.
https://doi.org/10.1371/journal.pone.0215703.g001
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The release of cytoplasmic contents
Melimine at its MIC or MBC released 49% and 51% of total cellular ATP respectively after 2
minutes of exposure (p<0.001) (Fig 5) and this amount of ATP did not increase after the initial
burst at 2 minutes. Within the first two minutes, melimine decreased live bacteria by approxi-
mately 1.4 log10 at its MIC and 1.5 at its MBC, although this was not statistically different to each
other and there was no further reduction in bacterial numbers to the end of the assay period (10
minutes). Compared with melimine, Mel4 released significantly (p>0.999) less ATP at its MIC
(19%) and MBC (21%) after 2 min (Fig 5), with no increase up to 10 minutes. There were< 0.5
log10 viable bacteria after 2 minutes incubation with Mel4 at its MIC or MBC, with no further
cell death over the remaining 8 minutes of the assay. Incubation with melimine released higher
amounts of ATP and produced more bacterial death (p<0.001) than Mel4 at the MICs or MBCs.
Release of DNA/RNA (260nm absorbing materials) is shown in Fig 6. Incubation with
melimine resulted in release of DNA/RNA from S. aureus in time dependent but dose inde-
pendent manner. Although increase in optical density first happened at 5 minutes with meli-
mine but it was not significant (p�0.083). A significant increase in the optical density
happened after 10 minutes exposure with increases of 1.7 times and 2.0 times at MIC and
MBC respectively (p<0.001). Moreover, optical density increased 4.8 times at MIC and 5.1
times at MBC after 150 minutes. On the hand, incubation with Mel4 did not increase optical
density at its MICs or MBCs over the course of 150 minutes of the assay (p�0.9945).
Bacterial lysis
At low bacterial concentrations (1× 108 CFU/ml), both the peptides showed no effect on opti-
cal density. This was probably due to bacterial concentration was too low to detect any change
Fig 2. Cell membrane depolarization. Cell membrane depolarization of S. aureus 38 as assessed with the release of membrane potential-sensitive dye DiSC3-(5)
during treatment with peptides, measured spectroscopically at 622nm to 670nm excitation and emission wavelengths, and corresponding bacterial death as
determined by plate counts. Each symbol represents data curve for increase in fluorescence (on the left y axis) and for reduction in bacterial count CFU/ml (on
the right y axis). Data are presented as means (±SD) of three independent repeats in triplicate. DMSO (20%) was used as a positive control and buffer used as a
negative control.
https://doi.org/10.1371/journal.pone.0215703.g002
Mechanism of action of cationic antimicrobial peptide Mel4
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Fig 3. Cell membrane permeabilization. Cell membrane permeability of S. aureus 38 was assessed with as the increase in fluorescence intensity due to
interaction of Sytox green dye with DNA (measured spectroscopically at 480nm excitation and 522nm emission wavelengths) at their MICs and MBCs of
melimine and Mel4. Data are presented as means (±SD) of three independent repeats in triplicate. Triton-X 100 (1%) was used as a positive control and buffer
only as a negative control.
https://doi.org/10.1371/journal.pone.0215703.g003
Fig 4. Flow cytometry. Cell membrane permeabilization of S. aureus 38 as determined with Syto-9 (membrane permeable) and Propidium Iodide (membrane
impermeable stains) dyes using Flow cytometry.
https://doi.org/10.1371/journal.pone.0215703.g004
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in optical density. However, when higher inoculum size of 1× 1010 CFU/ml was used and
treated with various concentration of peptides, a significant reduction in optical density was
Fig 5. Leakage of ATP. The leakage of cellular ATP (in percentage) from S. aureus 38 after treatment with MIC or MBC of each peptide shown at X axis. The
corresponding change in the number of live cells (CFU/ml) estimated through viable count displayed at Y axis. Each symbol represents data curve for increase
in fluorescence (on the left y axis) and for reduction in bacterial count CFU/ml (on the right y axis). Errors bars represent the means (±SD) of three
independent experiments in triplicate compared with buffer-treated control.
https://doi.org/10.1371/journal.pone.0215703.g005
Fig 6. Release of DNA/RNA. The release of UV absorbing materials (DNA/RNA) from S. aureus 38 determined spectroscopically at OD260nm.after incubation
with MIC or MBC of melimine and Mel4. Data are presented as means (±SD) of three independent repeats in triplicate compared with buffer-treated control.
https://doi.org/10.1371/journal.pone.0215703.g006
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observed at 6.5 hours (Fig 7). At this time point, melimine reduced optical density by 21±1%
at its MIC and 31±4% at its MBC compared to buffer treated control (p<0.001) (Fig 7). Meli-
mine lysed more than 42% cells after 24 h. A similar trend was observed for Mel4 which
reduced optical density by 22±3% and 25±2% at its MICs and MBCs respectively after 6.5 h
(Fig 7). After 24 h of incubation, Mel4 caused lysis of more than 40% cells. Over 24 hours the
bacterial-lytic efficiency of both melimine and Mel4 was similar and no significant difference
was observed (p�0.851). The optical density of control cells (buffer treated) remained
unchanged over the 24 h of the experiment.
The killing kinetics of AMPs was determined by exposing S. aureus to their MIC and MBC.
Melimine reduced the number of cells by 1.1 log10 at its MIC and 1.2 log10 CFU/ml at its MBC
after 2 h of incubation (Fig 8). At its MIC, after 2 hours melimine continued to reduce the
numbers of live cells, but the rate of reduction diminished after 12 hours. The initial rate of
reduction from 0–2 h was 6.6 CFU log10/ml/hour, from 2–12 hours was 5.9 CFU log10/ml/
hour and from 12–24 h was 2.9 CFU log10/ml/hour. At its MBC, the initial rate of reduction
was 6.7 CFU log10/ml/hour, then from 2–24 h the rate remained constant at 5.7 CFU log10/ml/
hour. Mel4 at its MIC did not significantly reduce bacterial viability within the first 2 h. The
rate of reduction from 2–12 h was 5.6 CFU log10/ml/hour and 3.8 CFU log10/ml/hour from
12–24 h. At its MBC the rate of reduction was also negligible initially (0–2 h), however, from
2–24 h the rate of reduction increased to 5.5 CFU log10/ml/hour. Killing rate of melimine from
2–24 was significantly higher than Mel4 (p<0.001). The bacterial viability remained unaffected
in control (buffer treated) over 24 h of the experiment.
Fig 7. Bacterial lysis. Bacterial lysis of S. aureus 38 was determined spectroscopically as decrease in OD620nm after incubation with MIC and MBC of melimine
and Mel4. Data are shown as means (±SD) of three independent repeats in triplicate compared with buffer-treated control. � represent p<0.001 and �� p<0.0001.
https://doi.org/10.1371/journal.pone.0215703.g007
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Autolytic activity
Autolytic activity of peptide-treated S. aureus supernatants was tested using PGN as the sub-
strate. The supernatant of Mel4 treated S. aureus had a higher reduction of OD570nm of PGN
suspension than melimine treated or controls (bacteria grown in the absence of peptides) (Fig
9A). The supernatants of Mel4 treated S. aureus resulted in a decrease in PGN density of 17
±3% which was significantly more compared with melimine treated (8±2%; p = 0.004) and
controls (7±1%, p<0.001) at 60 min ((Fig 9A). The reduction in PGN density caused by meli-
mine or buffer supernatants was not significantly different at each time point (p = 0.999). The
rate of PGN degradation for Mel4 was 0.28% OD570/min up to 60 mins and then there was no
more activity from 60–180 minutes. The rate for lysozyme was 0.7% OD570/min within first 30
minutes. Lysozyme produced higher PGN hydrolysis, decreasing OD 21±4% at 30 min. The
autolysis of culture supernatants was also examined using a pre-seeded lawn of Micrococcus
lysodeikticus. Melimine or Mel4 suspended in buffer and treated in the same way as culture
supernatants of S. aureus did not produce any zone of inhibition, showing that the peptides
must either have been destroyed or removed during processing. The supernatant from Mel4
treated cells produced a zone of inhibition of 8±1 mm (Fig 9IIA) whereas for melimine and
buffer treated cells smaller zones of inhibtion of 5±1 mm were produced (Fig 9IA). The posi-
tive control lysozyme formed largest 12±2 mm zone of inhibition.
Lysis of horse red blood cells
Melimine and Mel4 exhibited dose dependent hemolytic effects against HRBCs. Melimine
started to hemolyse HRBCs (6%) at 264.08 μM. Significant lysis (17%) occurred at higher
518.16 μM concentrate.on (p<0.001; Fig 10). Compared with melimine, Mel4 showed less
hemolysis at their corresponding MICs. The first appreciable hemolysis of HRBCs by Mel4
Fig 8. Bacterial killing kinetics. Time kill kinetics of melimine and Mel4 against S. aureus 38. Aliquotes analyzed at different time intervals for viable count
showed that peptides decrease the bacterial viability (log10 CFU/ml) with different rates compared to buffer treated (negative control).
https://doi.org/10.1371/journal.pone.0215703.g008
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(5%) was observed at 1703.68 μM (p<0.041). However, exposure to 3407.36 μM resulted in
slightly higher lysis (6%) of HRBCs (p<0.022). The therapeutic index (that is hemolytic con-
centration/MIC) was 16 for both melimine and Mel4.
Discussion
The current study demonstrated that the mode of action of S. aureus killing by Mel4 and its
precursor melimine were different. A previous study had shown that 30 minutes incubation
Fig 9. Detection of autolysins release. (A) Release of autolysins was determined by measuring decrease in OD570nm of PGN suspensions following treatment with cell-
free supernatants of melimine and Mel4 treated S. aureus 38 (S38). Cell-free supernatants from Mel4 treated S. aureus resulted in a greater degradation of PGN than
those from melimine or buffer treated S. aureus. Data presented as means (±SD) of three independent repeats in triplicate. � represent p�0.004 compared to melimine
treated bacteria and �� p<0.001 compared to buffer control (B) Release of autolysins was also monitored by determining the zone of inhibition (arrow) of cell-free
supernatants against Micrococcus lysodeikticus ATCC 4698 after (I) melimine and (II) Mel4 treatment. 1A = supernatant from melimine treated S. aureus 38, IIA
supernatant from Mel4 treated S. aureus, IB and IIB zones produced by lysozyme (5 mg/ml), IC no zone produced when melimine was incubated with buffer alone, IIC
Mel4 incubated with buffer alone, ID and IID S. aureus incubated without addition of melimine or Mel4.
https://doi.org/10.1371/journal.pone.0215703.g009
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with melimine can distort S. aureus cells, induce bleb formation and accummulation of cell
debris [30], as well as being able to permeabilise the cytoplasmic membrane of S. aureus in a
concentration independent manner [30]. The previous study also showed that melimine was
only able to produce <1 log10 reduction in numbers of S. aureus cells when incubated for up
to five minutes. The current study demonstrated similar effects, but extended this to demon-
strate that melimine could interact with LTA of S. aureus and produce beakage in the cyto-
plasmic membrane of S. aureus that resulted in leakage of intracellular contents (ATP and
DNA/RNA) eventually leading to cell lysis and death. Melimine was also able to liberate a
small amount of autolysins from the staphylococcal cells. Whilst Mel4 could also interact with
LTA and depolarise the cytoplasmic membrane. It had a weaker effect on producing pores
which was evidenced by negligible Sytox green intake by cells, minimum disruption to cyto-
plasmic membrane compared to melimine and minimum propidium iodide staining. Based
on the flow cytometry data it is suggested that it can cause transient cell membrane permeabil-
ity. In addition, less ATP was released from Mel4-treated cells and no DNA/RNA was released
Fig 10. Hemolysis of horse erythrocytes. Hemolysis was determined as increase in OD540nm after incubation with increasing concentration of the melimine
and Mel4. Errors bars represents the means (±SD) of three independent experiments performed at three separate occasion in triplicate.
https://doi.org/10.1371/journal.pone.0215703.g010
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over 150 minutes. However, both the peptides eventually resulted in cell lysis and death after
24 hours exposure. Mel4-treated cells released greater amount of autolysins compared to meli-
mine-treated ones. It is probable that the main killing mechanism of Mel4 was release of auto-
lysins from LTA in cell walls along with membrane depolarization. Live bacteria produce a
proton gradient outside the cell membrane, and the protons can accumulate in the cell walls
and protonate the D-Alanine ester linkages of LTA [55]. The protonation of D-Ala ester link-
ages lowers the pH of the cell wall which in turn suppress the activity of autolysins bound to
LTA [55]. Upon dissipation of the membrane protentional, deprotonation of the D-Ala ester
linkages of LTA raises the pH of the cell wall resulting in activation of autolysins [55, 56].
Moreover, the membrane embedded glycolipid anchor of LTA plays an important role in its
inhibitory effect on autolysins [57]. Antimicrobial peptides cause the delocalization of the gly-
colipid anchor and subsequently release autolysins by disrupting the cell membrane [57].
Therefore, the membrane depolarization caused by melimine and Mel4 may leads to LTA
deprotonation and release of LTA which in turn liberates autolysins.
There are substantial differences in the amino acid compositions of Mel4 and melimine
which contains 17 and 29 amino acids respectively. The lack of tryptophan in the sequence of
Mel4 may be important in the differences in modes of action. Tryptophan (Trp) is known to
interact with lipid bilayers, can enhance peptide-membrane interactions and facilitate inser-
tion of peptides into the membrane [35, 58]. Trp and Arginine (Arg) together are known to
promote stable and deeper insertion into the cell wall of Gram-positive bacteria [59]. Trp facil-
itates the insertion of Arg into hydrophobic regions of membranes via cation–π interactions
causing rapid membrane disruption [35]. May be due to the presence of Trp, melimine can
adopt a partial α helix in bio-membrane mimetic environment [30]. The antimicrobial activity
of AMPs is often attributed to this helical conformation [60]. Mel4 lacks tryptophan and also
has a low hydrophobic moment (0.039), meaning that it is less likely to be attracted within
lipid bilayers [61]. Mel4 is unable to interact with lipid spheroids composed of 1-oleoyl-
2-hydroxy-sn-glycero-3-phosphocholine (PC 18:1) or tethered lipid bilayers composed of 70%
zwitterionic C20 diphytanyl-glycero-phosphatidylcholine lipid and 30% C20 diphytanyl-
diglyceride but melimine can interact with these lipid layers [62].
Both melimine and Mel4 could interact with LTA. This interaction is likely due to their pos-
itive charge and the negative charge of LTA given by its phosphate groups. Melimine has an
overall positive charge of +15, whilst Mel4 has +14 [32], and this small difference may partly
explain some of the different effects of their interactions with LTA. At their MICs, there were 3
times more molecules of Mel4 present than melimine yet the inhibition of bacterial growth
was not different, perhaps indicating a reduced ability of Mel4 to interact with LTA. In the
ELISA assay at their MICs or MBCs melimine neutralized approximately the same number of
LTA molecules as Mel4, further indicating a reduced Mel4-LTA interaction. However, this
was not the case with the amount of autolysis observed after incubation of S. aureus cell super-
natants with Micrococcus cells. LTA and teichoic acids bind to staphylococci cell wall and regu-
late the autolysins activity [63, 64], and addition of AMPs liberate autolysins [65].
A cytoplasmic membrane potential is essential for bacterial replication and ATP synthesis
[66]. Dissipation of the membrane potential can increase membrane permeability resulting in
loss of ATP [67]. Depletion of intracellular ATP can result in loss of viability of bacteria [66].
ATP leakage was associated with a increase of 1.5 log10 S. aureus bacterial death within 2 min
with melimine. However, release of ATP did not correlate with bacterial death with Mel4.
Melimine reduced bacterial viability in the ATP assay but not in the membrane depolarization
assay at same time point. This effect may be due to the presence of 100 mM KCl in the bacterial
suspension media of the membrane depolarization assay. KCl can increase the MIC of AMPs
against S. aureus [68]. The amount of ATP released by Mel4 plateaued after four minutes
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exposure and never reached to the level of melimine until 10 minutes exposure. ATP may be
depleted in the supernatant of Mel4 treated cells possibly by hydrolysis at their cell surfaces.
Mel4 released small amounts of ATP without permeabilizing the cell membrane. ATP being a
smaller molecule needs only a pore size of 1.5 nm to leak out from compromised membranes
[69]. Thus, pores size produced by Mel4 in the cell membrane are enough for ATP release as
they do not need well defined pores in the membrane to escape from bacteria.
Both melimine and Mel4 exhibited low hemolytic activity. The concentration at which both
the peptides started lysis of HRBCs was 16 times higher than their MICs. These results are
comparable with our previous published data where melimine produced 9% hemolysis of
sheep red blood cells at 20 times higher concentration than its MIC [28]. Compared to Mel4,
the slightly higher hemolytic activity of melimine at similar concentration may be related to
higher hydrophobicity, amphipathcity and helicity [70]. Melimine contains the hydrophobic
amino acids leucine, Isoleucine and tryptophan that can cause hemolysis of erythrocyte [71],
whereas Mel4 lacks all these hydrophobic amino acids is less hydrophobic in turn showed less
hemolytic activity against horse erythrocytes.
Conclusions
It is likely that the amphipathic characteristics of melimine allowed disruption of the cell mem-
branes and pore formation that resulted in ATP and DNA release and ultimately cell death.
However, Mel4 showed less interaction with cell membranes and its killing of S. aureus was
more likely due to activation autolysins along with minimum membrane disruption. A com-
prehensive timeline of the mechanism of action of melimine and Mel4 against S. aureus is
summarized in Fig 11.
Supporting information
S1 Table. Cell membrane depolarization. Cell membrane depolarization as assessed by the
release of the membrane potential sensitive dye DiSC3-5, measured spectroscopically at 622nm
excitation and 670nm emission wavelengths. Data are presented as means (±SD) of three
Fig 11. Timeline of melimine or Mel4 interacting with S. aureus. Both AMPs induced cell membrane depolarization after 30 seconds exposure to the staphylococci
followed by release of ATP after 2 minutes. Cell membrane permeabilization occurred with melimine only after 10 minutes with near simultaneous release of DNA/
RNA. Mel4 caused transient cell membrane after 30 minutes with no release of DNA/RNA. Mel4 showed autolysins induced killing after 5 hours. Complete bacterial
lysis started after 6.5 hours of incubation with both the peptides.
https://doi.org/10.1371/journal.pone.0215703.g011
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independent repeats performed in triplicate.
(PDF)
S2 Table. Reduction in number of live bacteria during treatment with the peptides. The
decrease in the number of viable bacteria (CFU/ml) that occurred at the same time as measur-
ing changes to their membrane depolarization. Data are presented as means (±SD) of three
independent repeats performed in triplicate.
(PDF)
S3 Table. Cell membrane permeabilization caused by the two peptides. Cell membrane per-
meabilization was assessed as the increase in fluorescence intensity due to interaction of Sytox
green dye with DNA (measured spectroscopically at 480nm excitation and 522nm emission
wavelengths). Data are presented as means (±SD) of three independent repeats performed in
triplicate.
(PDF)
S4 Table. Leakage of ATP from cells upon addition of the two peptides. The leakage of cel-
lular ATP (in percentage) from bacteria after treatment with 1X and 2X MIC of each peptide.
Data are presented as means (±SD) of three independent repeats performed in triplicate.
(PDF)
S5 Table. Reduction in number of live bacteria during treatment with peptides that
occurred in the ATP assay. Data are presented as means (±SD) of three independent repeats
performed in triplicate.
(PDF)
S6 Table. Release of DNA/RNA from cells upon addition of peptides. The release of UV
absorbing materials (DNA/RNA) was determined spectroscopically at OD260nm after treat-
ment with 1X and 2X MIC of peptides. Data are presented as means (±SD) of three indepen-
dent repeats performed in triplicate.
(PDF)
S7 Table. Bacterial lysis after addition of peptides. Bacterial lysis was determined as the
decrease in OD620nm (in percentage) after treatment with 1X and 2X MIC of peptides. Data are
presented as means (±SD) of three independent repeats performed in triplicate.
(PDF)
S8 Table. Hydrolysis of peptidoglycan after addition of cell-free supernatants of cells that
had been treated with peptides. The hydrolysis of peptidoglycan (PGN) was determined by
measuring decrease in OD570nm. Data are presented as means (±SD) of three independent
repeats performed in triplicate.
(PDF)
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